3 Things to Watch in Intuitive Surgical's Earnings Report

Source: Intuitive Surgical.

Intuitive Surgical (NASDAQ: ISRG  ) maker of the da Vinci Robotic Surgical System and market-leader in technology-assisted surgery, is slated to report earnings after the market closes Thursday. For investors who have suffered through a rough 2013 -- with shares trading down almost 20% since the beginning of the year -- here are three key areas to focus on when earnings are reported.

1. The basics
With any company reporting earnings, the quickest way to get a drive-by feel for how the company performed is to compare how revenue and earnings figures stack up against what Wall Street analysts were expecting.

Here's a look at what analysts will be looking for:


Earnings per Share




$526 million

Source: E*Trade.

These are both lower than what the company experienced during the third quarter of 2012. In fact, if Intuitive matches these expectations, it will represent a 4% decrease in earnings and a 2% drop in revenue.

The reason for such slow growth from a company that was growing like gangbusters leads to the second thing to look out for.

2. System sales in North America
Though Intuitive Surgical has a business model that breeds sustainability --through recurring revenue for parts and service on the installed base of da Vinci machines -- in order for the stock to be worth what it is today, it will need to continue convincing hospitals to buy the da Vinci.

During the second quarter of 2012, those sales dropped precipitously.

Source: SEC filings.

There was lots of speculation on why system sales slowed so much in the United States, ranging from the medical community questioning the efficacy of robotic surgery, to uncertainty surrounding the effects of the Patient Protection and Affordable Care Act.

During the third quarter of 2012, Intuitive sold 114 da Vinci units. Some Wall Street analysts, who have been on the phone with hospital administrators, are confident that the number of unit purchases will pick up once again. If Intuitive is able to show sales of around 114 units, it should be a positive sign for long-term investors that the trend is reversing.

3. Procedure growth
Finally, when it comes to recurring revenue -- which is extremely important for investors who would like to hold the stock for decades -- the amount of operations being performed with the da Vinci is extremely important. Last quarter, procedures grew by 18%, but the company noted weakness in hysterectomies.

With hysterectomies -- along with prostatectomies -- making up the vast majority of procedures performed with the da Vinci, investors should keep their ears open during the conference call to see if hysterectomies are showing continued weakness.

Is it a buy?
Where things stand now, Intuitive is definitely cheaper now than it has been in a while -- trading for just 23 times earnings and 21 times free cash flow. Over the last four years, the company's stock hasn't gotten anywhere near those values.

At the same time, there are serious questions to be resolved. That's why I'm not buying or selling my shares of Intuitive Surgical, which occupy just under 5% of my real-life holdings.

Our Foolish Founder David Gardner -- who has developed a unique strategy for uncovering truly wealth-changing stock picks -- might disagree with me. In a special 100% FREE report called "6 Picks for Ultimate Growth," he names Intuitive Surgical as one of his top six picks. To find out why he chose the company, and what the other five stocks are, click HERE.

Read/Post Comments (2) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 15, 2013, at 1:19 PM, MusiCali wrote:

    ISRG always trades like this. we are at the low range. one good quarter and we will go back to a p/e of 34+. Then in a year or so, it will float back down to the low end of its trading range.

  • Report this Comment On October 16, 2013, at 12:13 PM, ISRGer wrote:

    ISRG's robotic operating machine compels it to continue in a very favorable operating trend with compelling earrings growth. cws

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2682687, ~/Articles/ArticleHandler.aspx, 9/30/2016 4:51:14 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 4:00 PM
ISRG $719.99 Up +2.22 +0.31%
Intuitive Surgical CAPS Rating: ****